Lactate Dehydrogenase (LDH) Kit, Colorimetric, BioAssay™

Referência L1013-95-96T

Tamanho : 96Tests

Marca : US Biological

Solicitar mais informações

Contactar o distribuidor local :


Telefone : +1 850 650 7790


L1013-95 Lactate Dehydrogenase (LDH) Kit, Colorimetric, BioAssay™

Clone Type
Polyclonal
Shipping Temp
RT
Storage Temp
-20°C

Lactate Dehydrogenase (LDH) is an oxidoreductase which catalyzes the interconversion of lactate and pyruvate. When disease or injury affects tissues containing LDH, the cells release LDH into the bloodstream, where it is identified in higher than normal levels. Therefore, LDH is most often measured to evaluate the presence of tissue or cell damage. The non-radioactive colorimetric LDH assay is based on the reduction of the tetrazolium salt MTT in a NADH-coupled enzymatic reaction to a reduced form of MTT which exhibits an absorption maximum at 565nm. The intensity of the purple color formed is directly proportional to the enzyme activity.||Key Features:|High sensitivity and wide linear range: Use 3ul serum or plasma sample. The detection limit is 2IU/L, linear up to 200IU/L. ||Homogeneous and simple procedure: Simple “mix-and-measure” procedure allows reliable quantitation of LDH activity within 30 minutes.||Robust and amenable to HTS: All reagents are compatible with high throughput liquid handling instruments.||Applications:|Direct Assays: LDH activity in serum, plasma and other sources.|Characterization and Quality Control for LDH production.|Drug Discovery: Screen and evaluation of LDH modulators.||Kit Components: (100 tests in 96-well plates):|L1013-95A: Substrate Buffer, 1x20ml|L1013-95B: Diaphorase, 1x120ul|L1013-95C: NAD Solution, 1x1ml|L1013-95D: Calibrator, 1x1.5ml|L1013-95E: MTT Solution, 1x1.5ml ||Storage and Stability:|Store components at -20°C. Stable for 6 months after receipt. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap.

Applications
Important Note: This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications without the expressed written authorization of United States Biological.
References
1. Stentz R., et al. (2010). Controlled protein release from viable Lactococcus lactis cells. Appl. Environ. Microbiol. 76(9): 3026-3031.2. Lu F., et al. (2008). The effect of C1 inhibitor on intestinal ischemia and reperfusion injury. Am. J. Physiol. Gastrointest. Liver Physiol. 295(5): G1042-G1049. 3. Mittal R., et al. (2009). Brain damage in newborn rat model of meningitis by Enterobacter sakazakii: a role for outer membrane protein A. Lab. Invest. 89(3): 263-277.